Edgewise Therapeutics Inc... (EWTX)
29.05
1.53 (5.56%)
At close: Jan 15, 2025, 12:01 PM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 86.10M | 351.95M | 280.79M | 104.92M | 23.65M |
| Short-Term Investments | 232.30M | 329.95M | 265.22M | 24.18M | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 348.00K | 5.30M | 3.53M | 975.00K | n/a |
| Receivables | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 8.60M | 10.10M | 5.97M | 551.00K | 390.00K |
| Total Current Assets | 327.00M | 351.95M | 280.79M | 129.65M | 24.04M |
| Property-Plant & Equipment | 12.69M | 9.85M | 912.00K | 516.00K | 498.00K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 13.04M | 15.15M | 4.44M | 1.49M | 498.00K |
| Total Assets | 340.04M | 367.10M | 285.23M | 131.14M | 24.54M |
| Account Payables | 4.03M | 6.11M | 3.84M | 1.58M | 667.00K |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | 980.00K | 1.22M | n/a | n/a | n/a |
| Other Current Liabilities | 11.77M | 9.26M | 6.68M | 2.76M | 465.00K |
| Total Current Liabilities | 16.77M | 16.59M | 10.52M | 4.34M | 1.13M |
| Long-Term Debt | 4.43M | 3.80M | n/a | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | 329.00K | n/a | n/a |
| Total Long-Term Liabilities | 4.43M | 3.80M | 329.00K | 160.21M | 40.26M |
| Total Liabilities | 21.20M | 20.39M | 10.85M | 164.56M | 41.39M |
| Total Debt | 5.41M | 4.41M | n/a | 160.21M | 40.26M |
| Common Stock | 7.00K | 6.00K | 5.00K | n/a | n/a |
| Retained Earnings | -244.76M | -144.60M | -76.96M | -34.15M | -17.02M |
| Comprehensive Income | 99.00K | -1.35M | -514.00K | n/a | n/a |
| Shareholders Equity | 318.83M | 346.72M | 274.38M | -33.42M | -16.85M |
| Total Investments | 232.30M | 329.95M | 265.22M | 24.18M | n/a |